The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.
What can we help you find?
Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, discusses best uses for opioids, and when to use other pain medications. This video was filmed at the 54th ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.
Shared decision making is a tool used by health care professionals to educate more thoroughly, and communicate with their patients.
The statement pointed out that the spread of legalized marijuana products has increased the need for unified labeling requirements.
Expert panelists conclude their discussion with parting advice on the management of opioid-induced constipation.
Turning toward the future management of opioid-induced constipation, the panel defined unmet needs and potential evolutions in care.
Comprehensive insight regarding the cost and timing of peripherally acting mu-opioid receptor antagonist therapy in opioid-induced constipation.
Given the 3 available peripherally acting mu-opioid receptor antagonists for opioid-induced constipation, experts consider when to use a specific agent.
Danny Sanchez, vice president and general manager, Population Health Services for Omnicell, explains how technology can be used to monitor patients on opioids and intervene before an overdose. This video was filmed at the ASHP (American Society of Health-System Pharmacists) Midyear Clinical Meeting & Exhibition in Las Vegas.
Ubrogepant is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved by the agency for the acute treatment of migraine.
Considerations for the safety/efficacy profile of peripherally acting mu-opioid receptor antagonists, particularly given their administration route.
Key opinion leaders shift their attention to use of peripherally acting mu-opioid receptor antagonists in opioid-induced constipation.
Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, CEO of Remitigate, discusses how opioid and pain management guidelines have evolved. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.